The frequency of T regulatory cells modulates the survival of multiple myeloma patients: detailed characterisation of immune status in multiple myeloma

Por Giannopoulos, K, Kaminska, W, Hus, I, Dmoszynska, A
Publicado em 2012

Demystified …: Monoclonal antibodies

Por Nelson, P N, Reynolds, G M, Waldron, E E, Ward, E, Giannopoulos, K, Murray, P G
Publicado em 2000

Sorafenib improves rituximab and ofatumumab efficacy by decreasing the expression of complement regulatory proteins

Por Dwojak, M, Bobrowicz, M, Bil, J, Bojarczuk, K, Pyrzynska, B, Siernicka, M, Malenda, A, Lech-Maranda, E, Tomczak, W, Giannopoulos, K, Golab, J, Winiarska, M
Publicado no Blood Cancer J (2015)

The CIMT-monitoring panel: a two-step approach to harmonize the enumeration of antigen-specific CD8(+) T lymphocytes by structural and functional assays

Por Britten, C. M., Gouttefangeas, C., Welters, M. J. P., Pawelec, G., Koch, S., Ottensmeier, C., Mander, A., Walter, S., Paschen, A., Müller-Berghaus, J., Haas, I., Mackensen, A., Køllgaard, T., thor Straten, P., Schmitt, M., Giannopoulos, K., Maier, R., Veelken, H., Bertinetti, C., Konur, A., Huber, C., Stevanović, S., Wölfel, T., van der Burg, S. H.
Publicado em 2007